Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen Ends Ganitumab Study on Panel Recommendation
Amgen Ends Ganitumab Study on Panel Recommendation
Amgen Ends Ganitumab Study on Panel Recommendation
Submitted by
admin
on August 9, 2012 - 11:34am
Source:
NASDAQ.com
News Tags:
Ganitumab
Amgen
pancreatic cancer
Headline:
Amgen Ends Ganitumab Study on Panel Recommendation
Do Not Allow Advertisers to Use My Personal information
